Dewey Stedman
Head of Investor Relations
Replay available
United Therapeutics Corporation (NASDAQ: UTHR) Q1 2025 earnings conference call, held 2025-04-30. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chairperson and Chief Executive Officer
President and Chief Operating Officer
Analyst, TD Carbon
Executive Vice President of Product Development and Xenotransplantation
Analyst, JP Morgan
Analyst, Learing Partners
Analyst, Oppenheimer
Watch the replay and follow the connected company analysis, news, and investor updates for United Therapeutics Corporation.
WEBVTT 00:00:00.031 -- 00:00:05.039 Good morning and welcome to the United Therapeutics Corporation first quarter 2025 corporate 00:00:05.039 -- 00:00:11.005 update. My name is Dhawan and I will be your conference operator today. 00:00:11.288 -- 00:00:16.136 All participants on the call portion of this webcast will be in listen-only mode until 00:00:16.136 -- 00:00:19.661 the question and answer portion of this earnings call. 00:00:19.661 -- 00:00:23.768 If you would like to ask a question during that time, simply press star then the number 00:00:23.768 -- 00:00:26.525 one on your telephone keypad. 00:00:26.525 -- 00:00:31.010 If you would like to withdraw your question, simply press star then two on your telephone 00:00:31.010 -- 00:00:32.673 keypad. 00:00:32.673 -- 00:00:36.455 Please note, this call is being recorded. 00:00:36.537 -- 00:00:41.443 I would now like to turn the webcast over to Dewey Stedman, Head of Investor Relations 00:00:41.443 -- 00:00:44.968 at United Therapeutics. Please go ahead. 00:00:44.968 -- 00:00:49.894 Thank you, Dorwin, and good morning. It is my pleasure to welcome you to the United Therapeutics 00:00:49.894 -- 00:00:54.149 Corporation first quarter 2025 corporate update webcast. 00:00:54.149 -- 00:00:58.154 Remarks today will include forward-looking statements representing our expectations or 00:00:58.154 -- 00:01:02.720 beliefs regarding future events. These statements involve risks and uncertainties that 00:01:02.720 -- 00:01:05.864 may cause actual results to differ materially. 00:01:05.864 -- 00:01:10.310 Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information 00:01:10.310 -- 00:01:14.896 on these risks and uncertainties, and we assume no obligation to update these forward-looking 00:01:14.896 -- 00:0...